Literature DB >> 11264742

Partial characterization of polyfermenticin SCD, a newly identified bacteriocin of Bacillus polyfermenticus.

K H Lee1, K D Jun, W S Kim, H D Paik.   

Abstract

AIMS: To characterize polyfermenticin SCD, a newly identified bacteriocin of Bacillus polyfermenticus SCD. METHODS AND
RESULTS: Bacillus polyfermenticus SCD was identified as a bacteriocin producer with a bactericidal activity against Bacillus subtilis IFO 12113. Polyfermenticin SCD, named tentatively as the bacteriocin produced by B. polyfermenticus SCD, showed a narrow spectrum of activity against Gram-positive and Gram-negative bacteria, a yeast and moulds. Production of polyfermenticin SCD in a 5 l jar fermenter followed typical kinetics of primary metabolite synthesis. The antibacterial activity of polyfermenticin SCD on sensitive indicator cells disappeared completely by treatment with proteinase K, which indicates its proteinaceous nature. Polyfermenticin SCD seemed to be very stable throughout the pH range of 2.0 to 9.0, and it was relatively heat labile compared with other bacteriocins. Direct detection of polyfermenticin SCD activity on SDS-PAGE suggested that it had an apparent molecular mass of about 14.3 kDa.
CONCLUSIONS: Bacillus polyfermenticus SCD produced relatively heat-labile polyfermenticin SCD with a narrow spectrum of activity. SIGNIFICANCE AND IMPACT OF THE STUDY: Bacillus polyfermenticus SCD is a commercial probiotic which has been used for the treatment of long-term intestinal disorders. New findings on polyfermenticin SCD will be valuable in the evaluation of commercial probiotics. Polyfermenticin SCD can be used to control Bacillus spoilage organisms as a biological control agent.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11264742     DOI: 10.1046/j.1472-765x.2001.00876.x

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  10 in total

1.  The angiogenic effect of probiotic Bacillus polyfermenticus on human intestinal microvascular endothelial cells is mediated by IL-8.

Authors:  Eunok Im; Yoon Jeong Choi; Cho Hee Kim; Claudio Fiocchi; Charalabos Pothoulakis; Sang Hoon Rhee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11       Impact factor: 4.052

2.  Antibacterial Peptides, Probiotic Properties and Biopreservative Efficacy of Native Bacillus Species Isolated from Different Food Sources.

Authors:  Vadakedath Nithya; Prakash M Halami
Journal:  Probiotics Antimicrob Proteins       Date:  2012-12       Impact factor: 4.609

3.  The anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition.

Authors:  Elise L Ma; Yoon Jeong Choi; Jinyoung Choi; Charalabos Pothoulakis; Sang Hoon Rhee; Eunok Im
Journal:  Int J Cancer       Date:  2010-08-15       Impact factor: 7.396

Review 4.  Bacillus strains as human probiotics: characterization, safety, microbiome, and probiotic carrier.

Authors:  Na-Kyoung Lee; Won-Suck Kim; Hyun-Dong Paik
Journal:  Food Sci Biotechnol       Date:  2019-10-08       Impact factor: 2.391

5.  Purification and partial characterization of a thermostable antimicrobial protein from Bacillus subtilis FB123.

Authors:  Bihong Shi; Hong Zheng; Jianzhong Huang; Xiuzhen Luo; Xiaolei Luo
Journal:  World J Microbiol Biotechnol       Date:  2015-05-17       Impact factor: 3.312

6.  Bacteriocin Production by Bacillus Species: Isolation, Characterization, and Application.

Authors:  Victor Mercado; Jorge Olmos
Journal:  Probiotics Antimicrob Proteins       Date:  2022-07-26       Impact factor: 5.265

7.  Bacillus polyfermenticus ameliorates colonic inflammation by promoting cytoprotective effects in colitic mice.

Authors:  Eunok Im; Yoon Jeong Choi; Charalabos Pothoulakis; Sang Hoon Rhee
Journal:  J Nutr       Date:  2009-08-12       Impact factor: 4.798

8.  An Antimicrobial Metabolite from Bacillus sp.: Significant Activity Against Pathogenic Bacteria Including Multidrug-Resistant Clinical Strains.

Authors:  Ajay G Chalasani; Gunaseelan Dhanarajan; Sushma Nema; Ramkrishna Sen; Utpal Roy
Journal:  Front Microbiol       Date:  2015-12-15       Impact factor: 5.640

9.  Secondary metabolites from Bacillus amyloliquefaciens isolated from soil can kill Burkholderia pseudomallei.

Authors:  Patcharaporn Boottanun; Chotima Potisap; Julian G Hurdle; Rasana W Sermswan
Journal:  AMB Express       Date:  2017-01-04       Impact factor: 3.298

10.  Genome Sequence of the Probiotic Strain Bacillus velezensis Variant polyfermenticus GF423.

Authors:  Haeyoung Jeong; JungAe Kim; Soo-Keun Choi; Jae-Gu Pan
Journal:  Microbiol Resour Announc       Date:  2018-09-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.